SEER CLOUD Trademark

Trademark Overview


On Thursday, October 7, 2021, a trademark application was filed for SEER CLOUD with the United States Patent and Trademark Office. The USPTO has given the SEER CLOUD trademark a serial number of 79324502. The federal status of this trademark filing is REGISTERED as of Tuesday, October 1, 2024. This trademark is owned by Seer Medical Pty Ltd. The SEER CLOUD trademark is filed in the Computer & Software Products & Electrical & Scientific Products category with the following description:

Downloadable computer programs for medical purposes for diagnosis, monitoring, management and treatment of neurological conditions; downloadable computer programs for health purposes for diagnosis, monitoring, management and treatment of neurological conditions; downloadable computer application software for use in the provision of and access to medical treatment relating to neurological and cardiac conditions and sleep disorders; downloadable computer application software for the provision of diagnostic medical and health information for use in body monitoring relating to neurological and cardiac conditions and sleep disorders including the management of epilepsy, heart and sleep disorder; downloadable computer application software for recording, collection, organisation, management and transmission of medical and health information relating to neurological and cardiac conditions and sleep disorders; downloadable software for use with medical devices for diagnosis, monitoring, managem...
seer cloud

General Information


Serial Number79324502
Word MarkSEER CLOUD
Filing DateThursday, October 7, 2021
Status700 - REGISTERED
Status DateTuesday, October 1, 2024
Registration Number7518172
Registration DateTuesday, October 1, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 4, 2022

Trademark Statements


NOT AVAILABLE"CLOUD"
Goods and ServicesDownloadable computer programs for medical purposes for diagnosis, monitoring, management and treatment of neurological conditions; downloadable computer programs for health purposes for diagnosis, monitoring, management and treatment of neurological conditions; downloadable computer application software for use in the provision of and access to medical treatment relating to neurological and cardiac conditions and sleep disorders; downloadable computer application software for the provision of diagnostic medical and health information for use in body monitoring relating to neurological and cardiac conditions and sleep disorders including the management of epilepsy, heart and sleep disorder; downloadable computer application software for recording, collection, organisation, management and transmission of medical and health information relating to neurological and cardiac conditions and sleep disorders; downloadable software for use with medical devices for diagnosis, monitoring, management and treatment of neurological conditions; downloadable software for use with medical diagnostic devices for diagnosis, monitoring, management and treatment of neurological conditions; downloadable software for use with health monitoring devices for diagnosis, monitoring, management and treatment of neurological conditions; downloadable software for use in the treatment of epilepsy for monitoring and diagnosing neurological diseases; downloadable software for use in the management of epilepsy for monitoring and diagnosing neurological diseases; downloadable electronic publications in the nature of scientific and medical research journal articles in the field of medical treatment for neurological and cardiac conditions and sleep disorders; downloadable electronic publications in the nature of scientific and medical research journal articles for providing information to patients and doctors in relation to epilepsy and other neurological conditions and the diagnosis, monitoring, management and treatment thereof; downloadable computer database programs relating to medical and health information for diagnosis, monitoring, management and treatment of neurological conditions; none of the foregoing in relation to reagents, software or hardware for the analysis of proteins, proteomes, or biological data, and goods and services in the fields of biomolecules, metabolomics, lipidomics, genomics, epigenomics, proteomics, transcriptomics, and secretomics

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateMonday, November 1, 2021
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSeer Medical Holdings Limited
Party Type31 - New Owner After Registration
Legal Entity Type81 - NOT AVAILABLE
AddressAU

Party NameSeer Medical Pty Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAU

Party NameSeer Medical Pty Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAU

Party NameSeer Medical Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAU

Trademark Events


Event DateEvent Description
Thursday, October 28, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, November 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 5, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, December 7, 2021ASSIGNED TO EXAMINER
Friday, December 17, 2021NON-FINAL ACTION WRITTEN
Saturday, December 18, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, January 12, 2022REFUSAL PROCESSED BY MPU
Wednesday, January 12, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, January 30, 2022REFUSAL PROCESSED BY IB
Sunday, May 8, 2022LIMITATION OF GOODS RECEIVED FROM IB
Thursday, July 7, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 7, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 8, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 25, 2022LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Monday, August 29, 2022ASSIGNED TO LIE
Monday, August 29, 2022DATA MODIFICATION COMPLETED
Tuesday, August 30, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 14, 2022NOTICE OF PUBLICATION
Wednesday, September 14, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 14, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, October 3, 2022NOTIFICATION PROCESSED BY IB
Tuesday, October 4, 2022PUBLISHED FOR OPPOSITION
Thursday, November 3, 2022EXTENSION OF TIME TO OPPOSE RECEIVED
Wednesday, March 29, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, March 29, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, March 31, 2023OPPOSITION NOTICE (IB REFUSAL) CREATED
Friday, March 31, 2023OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Monday, April 3, 2023OPPOSITION INSTITUTED NO. 999999
Wednesday, April 19, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Monday, May 1, 2023REFUSAL PROCESSED BY IB
Thursday, August 22, 2024OPPOSITION DISMISSED NO. 999999
Thursday, August 22, 2024OPPOSITION TERMINATED NO. 999999
Thursday, August 22, 2024TTAB RELEASE CASE TO TRADEMARKS
Tuesday, October 1, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, October 1, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Friday, October 11, 2024CHANGE OF NAME/ADDRESS REC'D FROM IB
Wednesday, January 1, 2025FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 4, 2025GENERIC MADRID TRANSACTION CREATED
Tuesday, March 4, 2025GENERIC MADRID TRANSACTION SENT TO IB
Saturday, April 19, 2025FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, November 7, 2025NEW REPRESENTATIVE AT IB RECEIVED